Skip to main content
Top
Published in: Digestive Diseases and Sciences 12/2015

01-12-2015 | Original Article

Multiple Opportunistic Pathogens, but Not Pre-existing Inflammation, May Be Associated with Necrotizing Enterocolitis

Authors: Steven T. Leach, Kei Lui, Zin Naing, Scot E. Dowd, Hazel M. Mitchell, Andrew S. Day

Published in: Digestive Diseases and Sciences | Issue 12/2015

Login to get access

Abstract

Background

Necrotizing enterocolitis (NEC) leads to significant morbidity and mortality in the neonatal intensive care unit. Although current evidence would suggest that bacteria contribute to the pathogenesis of NEC, no single bacterium has yet been identified.

Aims

The aims of this study were to investigate fecal S100A12 concentrations and the intestinal bacterial community in premature infants (24–32 weeks) and investigate any associations between the microbiota and the development of NEC.

Methods

Meconium and feces were collected from premature newborn infants (between 24 and 32 weeks gestation) over the first 4 weeks of life. Fecal S100A12 concentrations were assayed by immunoassay, and samples were subject to 16S rDNA analysis using next-generation sequencing techniques.

Results

Fecal samples were collected from four infants that developed NEC and 18 control infants. Prior to developing NEC, fecal S100A12 concentrations were not elevated; however, following NEC diagnosis, concentrations were highly elevated. The fecal bacterial communities of infants with NEC did not differ significantly from control infants. However, potentially pathogenic bacteria were detected in significantly more infants with NEC than in controls (p = 0.0007).

Conclusion

At birth, fecal S100A12 concentrations were not elevated in premature infants subsequently developing NEC in this cohort. Following NEC diagnosis, S100A12 concentrations were highly elevated, suggesting that this potentially could act as a marker of disease progression. Higher detection rates of potentially pathogenic bacteria in NEC infants suggest that a range of potentially pathogenic bacteria may collectively contribute to NEC pathogenesis.
Literature
2.
go back to reference Morgan JA, Young L, McGuire W. Pathogenesis and prevention of necrotizing enterocolitis. Curr Opin Infect Dis. 2011;24:183–189.CrossRefPubMed Morgan JA, Young L, McGuire W. Pathogenesis and prevention of necrotizing enterocolitis. Curr Opin Infect Dis. 2011;24:183–189.CrossRefPubMed
3.
go back to reference Alfaleh K, Anabrees J, Bassler D, Al-Kharfi T. Probiotics for prevention of necrotizing enterocolitis in preterm infants Cochrane Database Syst Rev. 2011;CD005496. Alfaleh K, Anabrees J, Bassler D, Al-Kharfi T. Probiotics for prevention of necrotizing enterocolitis in preterm infants Cochrane Database Syst Rev. 2011;CD005496.
4.
go back to reference Wang Y, Hoenig JD, Malin KJ, et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J. 2009;3:944–954.PubMedCentralCrossRefPubMed Wang Y, Hoenig JD, Malin KJ, et al. 16S rRNA gene-based analysis of fecal microbiota from preterm infants with and without necrotizing enterocolitis. ISME J. 2009;3:944–954.PubMedCentralCrossRefPubMed
5.
go back to reference Guignard F, Mauel J, Markert M. Identification and characterization of a novel human neutrophil protein related to the S100 family. Biochem J. 1995;309:395–401.PubMedCentralCrossRefPubMed Guignard F, Mauel J, Markert M. Identification and characterization of a novel human neutrophil protein related to the S100 family. Biochem J. 1995;309:395–401.PubMedCentralCrossRefPubMed
6.
go back to reference Foell D, Kucharzik T, Kraft M, et al. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut. 2003;52:847–853.PubMedCentralCrossRefPubMed Foell D, Kucharzik T, Kraft M, et al. Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut. 2003;52:847–853.PubMedCentralCrossRefPubMed
7.
go back to reference de Jong NS, Leach ST, Day AS. Fecal S100A12: a novel noninvasive marker in children with Crohn’s disease. Inflamm Bowel Dis. 2006;12:566–572.CrossRefPubMed de Jong NS, Leach ST, Day AS. Fecal S100A12: a novel noninvasive marker in children with Crohn’s disease. Inflamm Bowel Dis. 2006;12:566–572.CrossRefPubMed
8.
go back to reference Andreotti R, Perez de Leon AA, Dowd SE, Guerrero FD, Bendele KG, Scoles GA. Assessment of bacterial diversity in the cattle tick Rhipicephalus (Boophilus) microplus through tag-encoded pyrosequencing. BMC Microbiol. 2011;11:6.PubMedCentralCrossRefPubMed Andreotti R, Perez de Leon AA, Dowd SE, Guerrero FD, Bendele KG, Scoles GA. Assessment of bacterial diversity in the cattle tick Rhipicephalus (Boophilus) microplus through tag-encoded pyrosequencing. BMC Microbiol. 2011;11:6.PubMedCentralCrossRefPubMed
9.
go back to reference Bailey MT, Dowd SE, Parry NM, Galley JD, Schauer DB, Lyte M. Stressor exposure disrupts commensal microbial populations in the intestines and leads to increased colonization by Citrobacter rodentium. Infect Immun. 2010;78:1509–1519.PubMedCentralCrossRefPubMed Bailey MT, Dowd SE, Parry NM, Galley JD, Schauer DB, Lyte M. Stressor exposure disrupts commensal microbial populations in the intestines and leads to increased colonization by Citrobacter rodentium. Infect Immun. 2010;78:1509–1519.PubMedCentralCrossRefPubMed
10.
go back to reference Finegold SM, Dowd SE, Gontcharova V, et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe. 2010;16:444–453.CrossRefPubMed Finegold SM, Dowd SE, Gontcharova V, et al. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe. 2010;16:444–453.CrossRefPubMed
11.
go back to reference Handl S, Dowd SE, Garcia-Mazcorro JF, Steiner JM, Suchodolski JS. Massive parallel 16S rRNA gene pyrosequencing reveals highly diverse fecal bacterial and fungal communities in healthy dogs and cats. FEMS Microbiol Ecol. 2011;76:301–310.CrossRefPubMed Handl S, Dowd SE, Garcia-Mazcorro JF, Steiner JM, Suchodolski JS. Massive parallel 16S rRNA gene pyrosequencing reveals highly diverse fecal bacterial and fungal communities in healthy dogs and cats. FEMS Microbiol Ecol. 2011;76:301–310.CrossRefPubMed
12.
go back to reference DeSantis TZ, Hugenholtz P, Larsen N, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006;72:5069–5072.PubMedCentralCrossRefPubMed DeSantis TZ, Hugenholtz P, Larsen N, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006;72:5069–5072.PubMedCentralCrossRefPubMed
13.
go back to reference Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187:1–7.PubMedCentralCrossRefPubMed Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187:1–7.PubMedCentralCrossRefPubMed
15.
go back to reference Dabritz J, Jenke A, Wirth S, Foell D. Fecal phagocyte-specific S100A12 for diagnosing necrotizing enterocolitis. J Pediatr. 2012;161:1059–1064.CrossRefPubMed Dabritz J, Jenke A, Wirth S, Foell D. Fecal phagocyte-specific S100A12 for diagnosing necrotizing enterocolitis. J Pediatr. 2012;161:1059–1064.CrossRefPubMed
17.
go back to reference Superti SV SV, de Martins DS, Caierao J, et al. Corynebacterium striatum infecting a malignant cutaneous lesion: the emergence of an opportunistic pathogen. Rev Inst Med Trop Sao Paulo. 2009;51:115–116.PubMed Superti SV SV, de Martins DS, Caierao J, et al. Corynebacterium striatum infecting a malignant cutaneous lesion: the emergence of an opportunistic pathogen. Rev Inst Med Trop Sao Paulo. 2009;51:115–116.PubMed
18.
go back to reference Salen PN, Eppes S. Morganella morganii: a newly reported, rare cause of neonatal sepsis. Acad Emerg Med.. 1997;4:711–714.CrossRefPubMed Salen PN, Eppes S. Morganella morganii: a newly reported, rare cause of neonatal sepsis. Acad Emerg Med.. 1997;4:711–714.CrossRefPubMed
19.
go back to reference Krasna IH, Kurgan A, Noy S. Pseudomonas septicemia; necrotizing bowel lesions (NEC) and skin lesions in a 5-mo-old child. J Pediatr Surg. 1979;14:481–482.CrossRefPubMed Krasna IH, Kurgan A, Noy S. Pseudomonas septicemia; necrotizing bowel lesions (NEC) and skin lesions in a 5-mo-old child. J Pediatr Surg. 1979;14:481–482.CrossRefPubMed
20.
go back to reference Oteo J, Aracil B, Ignacio Alos J, Luis Gomez-Garces J. Significant bacteremias by Corynebacterium amycolatum: an emergent pathogen. Enferm Infecc Microbiol Clin. 2001;19:103–106.CrossRefPubMed Oteo J, Aracil B, Ignacio Alos J, Luis Gomez-Garces J. Significant bacteremias by Corynebacterium amycolatum: an emergent pathogen. Enferm Infecc Microbiol Clin. 2001;19:103–106.CrossRefPubMed
21.
go back to reference Fernandes N, Steinberg P, Rusch D, Kjelleberg S, Thomas T. Community structure and functional gene profile of bacteria on healthy and diseased thalli of the red seaweed Delisea pulchra. PLoS ONE. 2012;7:e50854.PubMedCentralCrossRefPubMed Fernandes N, Steinberg P, Rusch D, Kjelleberg S, Thomas T. Community structure and functional gene profile of bacteria on healthy and diseased thalli of the red seaweed Delisea pulchra. PLoS ONE. 2012;7:e50854.PubMedCentralCrossRefPubMed
Metadata
Title
Multiple Opportunistic Pathogens, but Not Pre-existing Inflammation, May Be Associated with Necrotizing Enterocolitis
Authors
Steven T. Leach
Kei Lui
Zin Naing
Scot E. Dowd
Hazel M. Mitchell
Andrew S. Day
Publication date
01-12-2015
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 12/2015
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-015-3830-6

Other articles of this Issue 12/2015

Digestive Diseases and Sciences 12/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.